*Company investments from the past five years, together with the forecast for 2026, are projected to reach EUR 500 million by year-end 2026, encompassing all expenditure on sustainability-related projects and health partnerships.*As part of this, Boe

*Supporting obesity and metabolic health with a USD 5 million contribution from Boehringer Ingelheim over three years*Collaboration will strengthen integrated care for obesity and related cardiovascular, kidney, liver and metabolic diseases to improv

Rabies remains one of the world's deadliest yet preventable zoonotic diseases, highlighting the need for sustained prevention efforts.Through a new multi-year collaboration, Boehringer Ingelheim and AWARE are expanding dog vaccination, populatio